Hepatic pathology in human monocytic ehrlichiosis: Ehrlichia chaffeensis infection

American Journal of Clinical Pathology

Volumn 119, Issue 6, 2003, Pages 859-865

  Sehdev, Ann E Smith ^b   Dumler, J Stephen ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NONE

Author keywords

Bile duct injury; Ehrlichia chaffeensis; Ehrlichiosis; Hematophagocytosis; Hepatopathology; Immunohistochemistry; Lobular hepatitis

Indexed keywords

ARTICLE; BILE DUCT INJURY; CELL INFILTRATION; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CELL DAMAGE; MONOCYTE; MYALGIA; PANCYTOPENIA; PHAGOCYTOSIS; PRIORITY JOURNAL; HISTIOCYTE; HYPERPLASIA; IMMUNOPHENOTYPING; ISOLATION AND PURIFICATION; LIVER; LYMPHOCYTE; MICROBIOLOGY; MONONUCLEAR CELL; PATHOLOGY; PHAGOCYTE; T LYMPHOCYTE;

KI 67 ANTIGEN;

EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; HISTIOCYTES; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KI-67 ANTIGEN; KUPFFER CELLS; LEUKOCYTES, MONONUCLEAR; LIVER; LYMPHOCYTES; MONOCYTES; PHAGOCYTES; T-LYMPHOCYTES;

EID: 0037533991     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/F7EA-B5P7-3217-16LJ     Document Type: Article

References (37)

1. Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am. 2002;86:375-392.
2. Dumler JS, Walker DH. Tick-borne ehrlichioses: more of them, higher incidences, and greater clinical diversity. Lancet Infect Dis. 2001;0:21-28.
3. Moskovitz M, Fadden R, Min T. Human ehrlichiosis: a rickettsial disease associated with severe cholestasis and multisystemic disease. J Clin Gastroenterol. 1991;13:86-90.
4. Sulkowski MS, Dumler JS. Clinical spectrum of disease due to Ehrlichia chaffeensis: case reports and review. Infect Dis Clin Pract. 1998;7:252-256.
5. Friedman AD, Daniel GK, Qureshi WA. Systemic ehrlichiosis presenting as progressive hepatosplenomegaly. South Med J. 1997;90:656-660.
6. Nutt AK, Raufman JP. Gastrointestinal and hepatic manifestations of human ehrlichiosis: 8 cases and a review of the literature. Dig Dis. 1998;17:37-43.
7. Walker DH, Dumler JS. Human monocytic and granulocytic ehrlichioses: discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med. 1997;121:785-791.
8. Lee EH, Rikihisa Y. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IκB-alpha and activation of NF-κB. Infect Immun. 1997;65:2890-2897.
9. Dumler JS, Brouqui P, Aronson J, et al. Identification of Ehrlichia in human tissue [letter]. N Engl J Med. 1991;325:1109-1110.
10. Dumler JS, Dawson JE, Walker DH. Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis. Hum Pathol. 1993;24:391-396.
11. Yu X, Brouqui P, Dumler JS, et al. Detection of Ehrlichia chaffeensis in human tissue by using species specific monoclonal antibody. J Clin Microbiol. 1993;31:3284-3288.
12. Barenfanger J, Prafulkumar GP, Dumler JS, et al. Identifying human ehrlichiosis. Lab Med. 1996;27:372-374.
13. Dawson JE, Paddock CD, Warner CK, et al. Tissue diagnosis of Ehrlichia chaffeensis in patients with fatal ehrlichiosis by use of immunohistochemistry, in situ hybridization, and polymerase chain reaction. Am J Trop Med Hyg. 2001;65:603-609.
14. Dumler JS, Sutker WL, Walker DH. Persistent infection with Ehrlichia chaffeensis. Clin Infect Dis. 1993;17:903-905.
15. Fichtenbaum CJ, Peterson LR, Weil GJ. Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med. 1993;95:351-357.
16. Maeda K, Markowitz N, Hawley RC, et al. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med. 1987;316:853-856.
17. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med. 1994;120:736-743.
18. Paddock CD, Suchard DP, Grumbach KL, et al. Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med. 1993;329:1164-1167.
19. Abbott KC, Vukelja SJ, Smith CE, et al. Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosis. Am J Hematol. 1991;38:230-234.
20. Marty AM, Dumler JS, Frisman DM, et al. Ehrlichiosis mimicking thrombotic thrombocytopenic purpura: case report and pathologic correlation. Hum Pathol. 1995;26:920-925.
21. Adams JS, Walker DH. The liver in Rocky Mountain spotted fever. Am J Clin Pathol. 1981;75:156-161.
22. Walker DH, Staiti A, Mansueto S, et al. Frequent occurrence of hepatic lesions in boutonneuse fever. Acta Trop. 1986;43:175-181.
23. Caldwell CW, Everett ED, McDonald G, et al. Apoptosis of gamma/delta T cells in human ehrlichiosis. Am J Clin Pathol. 1996;105:640-646.
24. Winslow GM, Yager E, Shilo K, et al. Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect Immun. 1998;66:3892-3899.
25. Sotomayor EA, Popov VL, Feng HM, et al. Animal model of fatal human monocytotropic ehrlichiosis. Am J Pathol. 2001;158:757-769.
26. Okada H, Tajima T, Kawahara M, et al. Ehrlichial proliferation and acute hepatocellular necrosis in immunocompetent mice experimentally infected with the HF strain of Ehrlichia, closely related to Ehrlichia chaffeensis. J Comp Pathol. 2001;124:165-171.
27. Hodzic E, Ijdo JW, Feng S, et al. Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis. 1998;177:737-745.
28. Bunnell JE, Trigiani ER, Srinivas SR, et al. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis. 1999;180:546-550.
29. Lepidi H, Bunnell JE, Martin ME, et al. Comparative pathology and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg. 2000;62:29-37.
30. Martin ME, Bunnell JE, Dumler JS. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis. 2000;181:374-378.
31. Ganta RR, Wilkerson MJ, Cheng C, et al. Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. Infect Immun. 2002;70:380-388.
32. Dumler JS, Trigiani ER, Bakken JS, et al. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol. 2000;7:6-8.
33. Akkoyunlu M, Fikrig E. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun. 2000;68:1827-1833.
34. Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol. 2002;5:130-140.
35. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601-608.
36. Antony SJ, Dummer JS, Hunter E. Human ehrlichiosis in a liver transplant recipient. Transplantation. 1995;60:879-881.
37. Arav-Boger R, Knepp JH, Walls JJ, et al. Human monocytic ehrlichiosis in a child with leukemia: Pediatr Infect Dis J. 2000;19:173-175.